What we found on the web about Imquest
ImQuest Presentations At Keystone Symposium Focus On Advancements In ...
ImQuest Life Sciences presented their latest biological results supporting the continued development of their small molecule pyrimidinedione inhibitors of HIV-1 at the Prevention ...
SynapseIndia - Our Clients - ImQuest Pharma
Client Brief: ImQuest Pharmaceuticals, Inc. is a leading drug discovery and development company that develops new, novel, first in class drugs for the ...
ImQuest BioSciences and Arisyn Therapeutics Announce Strategic ...
FOR IMMEDIATE RELEASE ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs ImQuest BioSciences and Arisyn ...
ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel ...
ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent 5/14/2009. FREDERICK, Md., May 14 /PRNewswire/ -- ImQuest BioSciences and ...
SynapseIndia - Our Clients - ImQuest BioSciences
Outsource your web site project or database driven application contracts. Outsourcing to your e-commerce web site application with your preferred partner for software development ...
ImQuest Pharmaceuticals, Inc: CEO & Executives - BusinessWeek
Get to know ImQuest Pharmaceuticals, Inc CEO & other corporate executives. Learn about the Board of Directors, Executive Committees and CEO compensation in this industry.
ImQuest Life Sciences, Inc. :: ImQuest BioSciences and Arisyn ...
ImQuest BioSciences and Arisyn Therapeutics jointly announced today that they have entered into a strategic drug development partnership to provide support necessary to develop ...
ImQuest and Arisyn Partner for Drug Development
ImQuest BioSciences and Arisyn Therapeutics have entered into a strategic drug development partnership to provide support necessary to develop Arisyn's portfolio of novel ...
ImQuest presents data on the anti-hepatitis B virus activity of ...
ImQuest Life Sciences today presented important new results on the continued development of the pyrimidinedione small molecules as antiviral agents at the 13th International ...
ImQuest Life Sciences, Inc. :: ImQuest Presentation at Keystone ...
ImQuest Life Sciences presented their latest biological results supporting the continued development of their novel small molecule piperazine compound for the treatment of solid ...
ImQuest Presentations At International HIV Meeting Highlight ...
ImQuest Life Sciences presented important new results on the continued development of their small molecule pyrimidinedione inhibitors of HIV-1 at the bi-annual HIV-DART meeting ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Imquest

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Imquest
BioSpectrum - Pharma - ImQuest to initiate HIV therapeutic trials with ...

ImQuest anticipates initiating their phase I studies in the first quarter of 2009. IQP-0410 is a novel small molecule inhibitor of HIV, which primarily acts as a non-nucleoside reverse transcriptase inhibitor (NNRTI). The company had licens...
ImQuest Submits Investigational New Product Application to the Food ...

FREDERICK, Md., Jan. 7 /PRNewswire/ -- ImQuest Life Sciences announced today the successful submission of an IND application to the Food and Drug Administration to initiate human clinical trials for their lead pyrimidinedione HIV inhibitor ...
Channel 4 KRNV.com: Local News and Weather for Reno-Tahoe Region ...
KRNV
FREDERICK, Md., Dec. 23 /PRNewswire/ -- ImQuest Life Sciences presented important new results on the continued development of their small molecule pyrimidinedione inhibitors of HIV-1 at the bi-annual HIV-DART meeting held this week in Puert...
ImQuest Submits Investigational New Product Application to the Food ...

FREDERICK, Md., Jan. 7 /PRNewswire/ -- ImQuest Life Sciences announced today the successful submission of an IND application to the Food and Drug Administration to initiate human clinical trials for their lead pyrimidinedione HIV inhibitor ...
ImQuest Receives Two Year Phase 2 SBIR Grant To Develop ...
Medical News Today
ImQuest BioSciences announced the successful acquisition of funding from the National Institute of Allergy and Infectious Disease (NIAID/NIH) to support the development of pyrimidinedione inhibitors as topical microbicides to prevent the se...
ImQuest Submits Investigational New Product Application To The Food ...
Medical News Today
ImQuest Life Sciences announced the successful submission of an IND application to the Food and Drug Administration to initiate human clinical trials for their lead pyrimidinedione HIV inhibitor IQP-0410. ImQuest anticipates initiating thei...
BioSpace - ImQuest Pharmaceuticals, Inc. News, Search Jobs, Events

ImQuest Pharmaceuticals, Inc. Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 1/7/2009 8:12:27 AM    More...
PharmaLive: ImQuest Submits Investigational New Product Application to ...
Phramalive.com
FREDERICK, Md., Jan. 7 /PRNewswire/ -- ImQuest Life Sciences announced today the successful submission of an IND application to the Food and Drug Administration to initiate human clinical trials for their lead pyrimidinedione HIV inhibitor ...
ImQuest Presentations at International HIV Meeting Highlight ...
Yahoo Finance
FREDERICK, Md., Dec. 23 /PRNewswire/ -- ImQuest Life Sciences presented important new results on the continued development of their small molecule pyrimidinedione inhibitors of HIV-1 at the bi-annual HIV-DART meeting held this week in Puert...